Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 0.56 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2700586 | 0.89 | CYP19A1 (0.58) | CYP19A1 | |
| Alpha-Phenyl-Gamma-Butyrolactone SCHEMBL7909086 | 0.78 | CYP19A1 (0.44) | CYP19A1CFTRGOPCTSHRCTRC | |
| Alpha-Phenyl-Gamma-Butyrolactone SCHEMBL6771142 | 0.78 | CYP19A1 (0.44) | CYP19A1CFTRGOPCTSHRCTRC | |
| SCHEMBL576513 | 0.78 | CYP19A1 (0.56) | CYP19A1 | |
| SCHEMBL9492304 | 0.78 | CYP19A1 (0.44) | CYP19A1CFTRGOPCTSHRCTRC | |
| Alpha-Phenyl-Gamma-Butyrolactone SCHEMBL576473 | 0.78 | CYP19A1 (0.44) | CYP19A1CFTRGOPCTSHRCTRC | |
| SCHEMBL23914271 | 0.77 | CYP19A1 (0.51) | CYP19A1CFTRGOPCTSHRCTRC | |
| SCHEMBL30674005 | 0.77 | CYP19A1 (0.51) | CYP19A1CFTRGOPCTSHRCTRC | |
| SCHEMBL14159692 | 0.77 | CTRC (0.43) | CYP19A1CFTRGOPCTSHRCTRC | |
| SCHEMBL576991 | 0.75 | TP53 (0.42) | CYP19A1CFTRGOPCTSHRCTRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888389-A4 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SURMODICS INC (US) | 2001-03-14 | — | — | EP | claimed |
| EP-0888389-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SurModics, Inc. (US) | 1999-01-07 | — | — | EP | claimed |
| WO-1997034935-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | BSI CORPORATION (US) | 1997-09-25 | — | — | WO | claimed |
| JP-9169753-A | — | — | None | — | — | JP | disclosed |
| CN-118496831-B | Water injection pitting corrosion inhibitor and preparation method thereof | 克拉玛依市华油精细化工有限责任公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118496831-A | Water injection pitting corrosion inhibitor and preparation method thereof | 克拉玛依市华油精细化工有限责任公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-110475776-B | Tricyclic carboxamides for combating arthropods | 拜耳作物科学股份公司 | 2024-03-19 | — | — | CN | disclosed |
| EP-3429567-B1 | METHODS AND COMPOSITIONS FOR TREATING OBESITY AND/OR DIABETES AND FOR IDENTIFYING CANDIDATE TREATMENT AGENTS | THE J DAVID GLADSTONE INST (US) | 2024-01-10 | — | — | EP | disclosed |
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814498-B2 | Polylactone foams and methods of making the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814498-B2 | Polylactone foams and methods of making the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| EP-0888389-B1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SURMODICS INC (US) | 2004-08-04 | — | — | EP | disclosed |
| EP-0888389-A4 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SURMODICS INC (US) | 2001-03-14 | — | — | EP | disclosed |
| US-5942555-A | Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom | SURMODICS, INC. (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0888389-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SurModics, Inc. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034935-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | BSI CORPORATION (US) | 1997-09-25 | — | — | WO | disclosed |
| JP-H09169753-A | PRODUCTION OF COMPOUND OF 2-OXETANONES | TOKUYAMA CORP | 1997-06-30 | — | — | JP | disclosed |
| EP-0586575-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992020738-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1992-11-26 | — | — | WO | disclosed |
| US-4029718-A | MOLDING MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | IDH1, IDH2, IDH3A | CYP19A1 235/4885CFTR 4276/4885GOPC 2362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.